Pasithea Therapeutics Corp
General ticker "KTTA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.0M
Pasithea Therapeutics Corp does not follow the US Stock Market performance with the rate: -45.3%.
Estimated limits based on current volatility of 4.1%: low 2.50$, high 2.72$
Factors to consider:
- Earnings expected soon, date: nan
- Current price 36.8% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [6.23$, 15.39$]
- 2023-12-31 to 2024-12-30 estimated range: [4.21$, 10.60$]
Short-term KTTA quotes
Long-term KTTA plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 |
---|---|---|
Operating Revenue | $0.02MM | $0.49MM |
Operating Expenses | $4.52MM | $15.30MM |
Operating Income | $-4.51MM | $-14.82MM |
Non-Operating Income | $2.33MM | $0.88MM |
Interest Expense | $0.00MM | $0.00MM |
R&D Expense | $0.00MM | $2.67MM |
Income(Loss) | $-2.17MM | $-13.94MM |
Taxes | $0.00MM | $-0.88MM |
Profit(Loss) | $-2.17MM | $-13.06MM |
Stockholders Equity | $51.42MM | $42.50MM |
Inventory | $0.00MM | $0.00MM |
Assets | $53.32MM | $45.18MM |
Operating Cash Flow | $-3.17MM | $-14.56MM |
Capital expenditure | $0.02MM | $2.14MM |
Investing Cash Flow | $-0.02MM | $-2.06MM |
Financing Cash Flow | $55.93MM | $-3.21MM |
Earnings Per Share* | $-1.89 | $-10.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.